Silverarc Capital Management, LLC Immunic, Inc. Transaction History

Silverarc Capital Management, LLC

  • $402 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$1.13 - $10.8 $396,241 - $3.79 Million
350,656 New
350,656 $490,000
Q2 2022

Jul 25, 2022
SELL
$3.13 - $12.25 $214,326 - $838,818
-68,475 Closed
0 $0
Q1 2022

May 13, 2022
BUY
$9.54 - $14.26 $653,251 - $976,453
68,475 New
68,475 $774,000

Others Institutions Holding IMUX

# of Institutions
74
Shares Held
56.5M
Call Options Held
100
Put Options Held
350K
View Full List

About IMMUNIC, INC.

IMUX Quotes by TradingView
  • Ticker IMUX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,565,000
  • Market Cap $29M
  • Description
  • Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...
More about IMUX
Track This Portfolio

Track Silverarc Capital Management, LLC Portfolio

Follow Silverarc Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silverarc Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email